A miRNA signature for defining aggressive phenotype and prognosis in gliomas.
Gliomas represent a disparate group of tumours for which there are to date no cure. Thus, there is a recognized need for new diagnostic and therapeutic approaches based on increased understanding of their molecular nature. We performed the comparison of the microRNA (miRNA) profile of 8 WHO grade II...
Main Authors: | Raffaela Barbano, Orazio Palumbo, Barbara Pasculli, Marco Galasso, Stefano Volinia, Vincenzo D'Angelo, Nadia Icolaro, Michelina Coco, Lucia Dimitri, Paolo Graziano, Massimiliano Copetti, Vanna Maria Valori, Evaristo Maiello, Massimo Carella, Vito Michele Fazio, Paola Parrella |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4184816?pdf=render |
Similar Items
-
Comparison between Real-Time Quantitative PCR Detection of HER2 mRNA Copy Number in Peripheral Blood and ELISA of Serum HER2 Protein for Determining HER2 Status in Breast Cancer Patients
by: Maria Savino, et al.
Published: (2009-01-01) -
Combined analysis of miR-200 family and its significance for breast cancer
by: Andrea Fontana, et al.
Published: (2021-02-01) -
High Specificity of Quantitative Methylation-Specific PCR Analysis for MGMT Promoter Hypermethylation Detection in Gliomas
by: Paola Parrella, et al.
Published: (2009-01-01) -
Hsa-miR-155-5p Up-Regulation in Breast Cancer and Its Relevance for Treatment With Poly[ADP-Ribose] Polymerase 1 (PARP-1) Inhibitors
by: Barbara Pasculli, et al.
Published: (2020-08-01) -
Can Epigenetics of Endothelial Dysfunction Represent the Key to Precision Medicine in Type 2 Diabetes Mellitus?
by: Celeste Coco, et al.
Published: (2019-06-01)